Dr Matthew Krebs, the study's chief investigator, tells Sky News its research was making "precision medicine" more accessible for a wider range of cancer patients. "There are tiny bits of DNA ...
If successful, researchers hope the procedure could become "routinely available on the NHS". Dr Matthew Krebs, the study's chief investigator, tells Sky News its research was making "precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback